Feasibility and ethics

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 11, 2013, Pages 1368-1369

  Price, David ^a,b   Roche, Nicolas ^b,c   Martin, Richard ^b,d   Chisholm, Alison ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Respiratory Effectiveness Group   (United Kingdom)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; EVALUATION; HEALTH CARE COST; HUMAN; LETTER; MEDICAL ETHICS; MEDICAL PROFESSION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

EID: 84890052159     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201307-1250LE     Document Type: Letter

References (6)

1. Albert RK. "Lies, damned lies ..." and observational studies in comparative effectiveness research. Am J Respir Crit Care Med 2013;187: 1173-1177.
2. Krishnan JA, Schatz M, Apter AJ. A call for action: comparative effectiveness research in asthma. J Allergy Clin Immunol 2011;127:123-127.
3. Janda S, Park K, FitzGerald JM, Etminan M, Swiston J. Statins in COPD: a systematic review. Chest 2009;136:734-743.
4. Simvastatin Therapy for Moderate and Severe COPD (STATCOPE). ClinicalTrials.gov identifier NCT01061671. 2010 [updated 2013 Oct 21; accessed 2013 Oct]. Available from: http://clinicaltrials.gov/ct2/show/NCT01061671? term=STATCOPE&rank=1
5. Giraud V, Allaert F-A, Roche N. Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med 2011; 105:1815-1822.
6. Lieu TA, Au D, Krishnan JA, Moss M, Selker H, Harabin A, Taggart V, Connors A; Comparative Effectiveness Research in Lung Diseases Workshop Panel. Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop. Am J Respir Crit Care Med 2011;184: 848-856.